| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 68513* | 2014 |
| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 9487 | 2020 |
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Emerging Risk Factors Collaboration The lancet 375 (9733), 2215-2222, 2010 | 6136 | 2010 |
| Evolocumab and clinical outcomes in patients with cardiovascular disease MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ... New England journal of medicine 376 (18), 1713-1722, 2017 | 6085 | 2017 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 5828 | 2021 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 5295 | 2021 |
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ... New England Journal of Medicine 369 (14), 1317-1326, 2013 | 4312 | 2013 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3668 | 2017 |
| Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ... The Lancet 375 (9716), 735-742, 2010 | 3291 | 2010 |
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3171 | 2013 |
| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 3165 | 2009 |
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Emerging Risk Factors Collaboration The Lancet 375 (9709), 132-140, 2010 | 2897 | 2010 |
| Lipoprotein (a) as a cardiovascular risk factor: current status BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ... European heart journal 31 (23), 2844-2853, 2010 | 2245 | 2010 |
| Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1937 | 2011 |
| Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ... The Lancet 373 (9677), 1765-1772, 2009 | 1878 | 2009 |
| Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality Emerging Risk Factors Collaboration JAMA: the journal of the American Medical Association 302 (4), 412, 2009 | 1858 | 2009 |
| Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ... European heart journal 32 (11), 1345-1361, 2011 | 1649 | 2011 |
| Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ... European heart journal 36 (17), 1012-1022, 2015 | 1597 | 2015 |
| C-reactive protein, fibrinogen, and cardiovascular disease prediction Emerging Risk Factors Collaboration New England Journal of Medicine 367 (14), 1310-1320, 2012 | 1336 | 2012 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1271 | 2020 |
Emanuele Di AngelantonioUniversity of Cambridge / Human TechnopoleEmail verificata su medschl.cam.ac.uk
